Surlid en es it fr

Surlid Brand names, Surlid Analogs

Surlid Brand Names Mixture

  • No information avaliable

Surlid Chemical_Formula


Surlid RX_link

No information avaliable

Surlid fda sheet

Surlid msds (material safety sheet)

Surlid Synthesis Reference

No information avaliable

Surlid Molecular Weight

906.628 g/mol

Surlid Melting Point

257 to 267 oC (decomposes with the evolution of gas)

Surlid H2O Solubility

No information avaliable

Surlid State


Surlid LogP

No information avaliable

Surlid Dosage Forms

Liquid (for injection)

Surlid Indication

For use as an anesthesia adjunct to induce skeletal muscle relaxation and to reduce the intensity of muscle contractions in convulsive therapy.

Surlid Pharmacology

Metocurine iodide is a benzylisoquinolinium competitive nondepolarizing neuromuscular blocking agent. Metocurine iodide has a moderate risk of inducing histamine release and has some ganglion blocking activity. Metocurine iodide can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation. As with other nondepolarizing neuromuscular blockers, the time to onset of paralysis decreases and the duration of maximum effect increases with increasing doses of metocurine iodide. Repeated administration of maintenance doses of metocurine iodide has no cumulative effect on the duration of neuromuscular block if recovery is allowed to begin prior to repeat dosing. Moreover, the time needed to recover from repeat doses does not change with additional doses. Repeat doses can therefore be administered at relatively regular intervals with predictable results.

Surlid Absorption

No information avaliable

Surlid side effects and Toxicity

Excessive doses can be expected to produce enhanced pharmacological effects. Overdosage may increase the risk of histamine release and cardiovascular effects, especially hypotension.

Surlid Patient Information

No information avaliable

Surlid Organisms Affected

Humans and other mammals